中国捍卫非专利药物的质量,反驳非专利药物不如西方药物有效的说法。 China defends the quality of generic drugs, countering claims they are less effective than Western drugs.

中国的卫生监管机构,即国家卫生安全管理局(NHSA),正在维护公立医院使用的非专利药物的质量。 China's health regulator, the National Healthcare Security Administration (NHSA), is defending the quality of generic drugs used in public hospitals. 这是因为人们担心这些非专利药物的效力低于西方公司生产的药物。 This came after concerns were raised that these generics were less effective than drugs made by Western companies. 国家保健服务机构认为这些关切是没有根据的,并强调其评价确保非专利药品符合原药的同样标准。 The NHSA found these concerns to be unsubstantiated and emphasized that their evaluations ensure generics meet the same standards as original drugs.